Synthesis of 1-acyl-2-alkylthio-1,2,4-triazolobenzimidazoles with antifungal, anti-inflammatory and analgesic effects

Acta Pharmaceutica

Volumn 56, Issue 1, 2006, Pages 31-48

  Mohamed, Bahaa G ^a   Abdel Alim, Abdel Alim M ^a   Hussein, Mostafa A ^a  

^a Assiut University   (Egypt)

Author keywords

1,2,4 triazolo 2,3 a benzimidazoles; 1,2 diaminobenzimidazole; Analgesic; Anti inflammatory activity; Antifungal; Hydroxylamine O sulfonic acid

Indexed keywords

1 ACETYL(TOSYL) 2 ALKYLTHIO 1,2,4 TRIAZOLO[2,3 A]BENZIMIDAZOLE; 1 ACYL 2 ALKYLTHIO 1,2,4 TRIAZOLOBENZIMIDAZOLE; 1 BENZOYL(P CHLOROBENZOYL) 2 ALKYLTHIO 1,2,4 TRIAZOLO[2,3 A] BENZIMIDAZOLE; 1,2,4 TRIAZOLO[2,3 A]BENZIMIDAZOLE 2 THIONE; 2 ALKYLTHIO 1,2,4 TRIAZOLO[2,3 A]BENZIMIDAZOLE; 2 PHENACYL 1,2,4 TRIAZOLO[2,3 A]BENZIMIDAZOLE; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIINFLAMMATORY AGENT; BENZIMIDAZOLE DERIVATIVE; FLUCONAZOLE; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANDIDA ALBICANS; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; FUSARIUM OXYSPORUM; LD 50; MALE; MOUSE; NONHUMAN; RAT; STOMACH ULCER;

EID: 32844460667     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. A. E. Abdel-Rahman, A. M. Mahmoud, G. M. EL-Naggar and H. A. EL-Sherief, Synthesis and biological activity of some new benzimidazolyl-azetidin-2-ones and thiazolidin-4-ones, Pharmazie 38 (1983) 589-590.
2. R. A. Coburn, M. T. Clarck, R. T. Evans and R. J. Genco, Substituted 2-(2-hydroxy phenyl)benzimidazoles as potential agents for the control of periodontal diseases, J. Med. Chem. 30 (1987) 205-208.
3. H. Foks and M. Janowiec, Synthesis and tuberculostatic activity of 2-pyrazinyl benzimidazole, Acta Pol. Pharm. 35 (1978) 281-288;
4. ref. Chem. Abst. 90 (1979) 168536m.
5. R. V. Devivar, E. Kawashima, G. R. Revankar, J. M. Breitenbach, E. D. Kreske, J. C. Drach and L. B. Townsend, Design, synthesis, and antiviral activity of certain 2-(alkylthio) and 2-(benzylthio) -5,6-dichloro-1-(β-D- ribofuranosyl) benzimidazoles, J. Med. Chem. 37 (1994) 2942-2949.
6. I. Islam, E. B. Skibo, R. T. Dorr and D. S. Alberts, Structure-activity studies of antitumor agents based on pyrrolo[1,2-a]benzimidazoles: New reductive alkylating DNA cleaving agents, J. Med. Chem. 34 (1991) 2954-2961.
7. K. Ito, H. Kagaya, T. Fukuda, K. Yoshino and T. Nose, Pharmacological studies of a new non-steroidal anti-inflammatory drug: 2-(5-ethylpyridin-2-yl) benzimidazole (KB-1043), Arzneim. Forsch. 32 (1982) 49-55.
8. A. Mertens, B. Muller-Beckmann, W. Kampe, J. P. Holck and W. von der Saal, 2-Pyridyl-6,7-dihydro-3H, 5H-pyrrolo[2,3-f]benzimidazol-6-ones, a novel class of cardiotonic agents, J. Med. Chem. 30 (1987) 1279-1289.
9. M. V. Kulkarni and V. D. Patil, Synthesis, spectral studies and anti-inflammatory activity of some new 2-aryloxybenzimidazoles, Arch. Pharm. 314 (1981) 440-447.
10. K. Kubo, Y. Inada, Y. Kohara, Y. Sugiura, M. Ojima, K. Itoh, Y. Furukawa, Y. K. Nishikawa and T. Naka, Nonpeptide angiotensin II receptor antagonist. Synthesis and biological activity of benzimidazoles, J. Med. Chem. 36 (1993) 1772-1784.
11. P. Demenge, G. Carraz, C. L. Due and C. Silice, Derivatives of benzimidazoles: Vasodilator activity of 2-(p-chloro-a-hydroxybenzyl)- benzimidazole hydrochloride, Arzneim. Forsch. 29 (1979) 628-630.
12. E. B. Akerblom and D. E. Campbell, Nitrofuryltriazole derivatives as potential urinary tract antibacterial agents, J. Med. Chem. 16 (1973) 312-319.
13. R. Bohm and C. Karow, Biologically active triazoles, Pharmazie 26 (1981) 243-247.
14. S. Kubota, M. Uda and K. Sato, Synthesis and antimicrobial activity of 3-alkylthio-5-pyridyl-1,2,4-triazoles and related compounds, Chem. Pharm. Bull. 26 (1978) 893-897.
15. I. Mir, M. T. Siddiqui and A. Camire, Antituberculosis agents: 1-α[5-(2-furyl)-1,2,4-triazol-3-ylthio] acetohydrazide and related compounds, Tetrahedron 26 (1970) 5235-5238.
16. H. Y. Hassan, A. A. El-Shorbagi, N. A. El-Koussi and A. O. Abdel-Zaher, Design and synthesis of some new 1H-1,2,4-triazoles of potential anti-inflammatory and analgesic activities, Bull. Pharm. Sci. 17 (1994) 27-39.
17. L. Savini, L. Chiasserini, C. Pellerano, W. Filippelli and G. Falcone, Synthesis and pharmacological activity of 1,2,4-triazolo[4,3-a]quinolines, Farmaco 56 (2001) 939-945.
18. B. Tozkoparan, G. Akaty and E. Yesilada, Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and anti-inflammatory activities, Farmaco 57 (2002) 145-152.
19. R. Rastogi and S. Sharma, 2-Aminobenzimidazole in organic syntheses, Synthesis 11 (1983) 861-882.
20. A. V. Zeiger and M. M. Joullié, Oxidation of 1,2- diaminobenzimidazoles to 3-amino-1,2,4-benzotriazines, J. Org. Chem. 42 (1977) 542-545.
21. H. William, Microbiological assay. An Introduction to Quantitative Principles and Evaluation, Academic Press, New York 1977.
22. L. V. G. Nargund, G. R. N. Reedy and V. Haripbasad, Antiinflammatory activity of substituted 1,3,4-oxadiazoles, J. Pharm. Sci. 83 (1994) 246-248.
23. E. A. Boyle, F. R. Mangan, R. E. Markwell, S. A. Smith, M. J. Thomson, R. W. Ward and P. A. Wyman, 7-Aroyl-2,3-dihydrobenzo[b]furan-3-carboxylic acids and 7-benzoyl-2,3-dihydrobenz[b] thiophene-3-carboxylic acids as analgesic agents, J. Med. Chem. 29 (1986) 894-897.
24. B. Tozkoparan, G. Akaty and E. Yesilada, Synthesis of some 1,2,4-triazolo[3,2-b]-1,3-thiazine-7-ones with potential analgesic and anti-inflammatory activities, Farmaco 57 (2002) 154-152.
25. F. Sztaricskai, I. E. Takacs, F. Pusztai, G. Szabo and I. Csipo, Antitubercular effect of the N- and O-β-D-glucopyranosides of 5-aminosalicylic acid, Arch. Pharm. Pharm. Med. Chem. 332 (1999) 321-326.
26. N. N. Gülerman, H. N. Dogan, S. Rollas, C. Johansson and C. Celik, Synthesis and structure elucidation of some new thioether derivatives of 1,2,4-triazoline-3-thione and their antimicrobial activities, Farmaco 56 (2001) 953-958.
27. D. M. Smith, Dihydrobenzimidazoles, Benzimidazolones, Benzimidazolethiones, and Related Compounds, in Benzimidazoles and Congeneric Tricyclic Compounds (Ed. P. N. Preston) [series: The Chemistry of Heterocyclic Compounds (Eds. A. Weissberger and A. C. Taylor)], Vol. 40, part I, Wiley, New York 1981, pp. 331.
28. th ed., Longman, Harlow 1989, pp. 1076-1248.
29. th ed. (Ed. N. Delgado and W. A. Remers), Lippincott-Raven, Philadelphia-New York 1998, pp. 185-190.
30. W. C. Black, C. Bayly, M. Belley, C. C. Chan, S. Charleson, D. Denis, J. Y. Gathier, R. Gordon, D. Guay, S. Kargman, C. K. Lau, Y. Leblanc, J. Mancini, M. Quellet, D. Percival, P. Roy, K. Skorey, P. Tagari, P. Vickers, E. Wong, L. Xu and P. Prasit, The pyrrole moiety as a template for COX-1/COX-2 inhibitors, Bioorg. Med. Chem. Lett. 6 (1996) 725-730.
31. A. S. Kalgutkar, A. B. Marrnett, B. C. Crews, R. P. Remmel and L. J. Marnett, Ester and amide derivatives of the nonsteroidal anti-inflammatory drug, Indomethacin, as selective cyclooxygenase-2 inhibitor, J. Med. Chem. 43 (2000) 2860-2870.
32. th ed. (Eds. J. N. Elgado and W. A. Remers), Lippincott-Raven, Philadelphia 1998, pp. 57-63.
33. B. Testa and P. Jenner, Drug Metabolism (Chemical Biotransformation Aspects), Marcel Dekker, New York 1976, pp. 10-24.